-
Moderna in talks with South Korea to supply 40 million doses of Covid-19 vaccine
pharmaceutical-business-review
January 06, 2021
Biotechnology company Moderna is negotiating with the South Korean government to potentially provide 40 million or more doses of its vaccine against Covid-19.
-
India gives restricted emergency use approval for two Covid-19 vaccines
pharmaceutical-business-review
January 06, 2021
India's Central Drugs Standard Control Organisation (CDSCO) has given the restricted emergency use approval for Covid-19 vaccines of Serum Institute of India and Bharat Biotech.
-
Israel authorises import of Moderna’s Covid-19 vaccine
pharmaceutical-technology
January 06, 2021
The Israeli Ministry of Health (MOH) has granted authorisation to import Moderna’s Covid-19 vaccine in the country.
-
Trane Technologies’ Thermo King launches cold chain solutions for COVID-19 vaccines in India
expresspharma
January 06, 2021
Thermo King’s SuperFreezers offer transport and storage of vaccines from a pharma company to the inoculation site by maintaining temperatures from +25° C to -70° C .
-
SII, Bharat Biotech jointly pledge to work for smooth roll out of COVID-19 vaccines
expresspharma
January 06, 2021
They said that the important task in front of them is saving the lives and livelihoods of populations in India and the world.
-
Speedy delivery of COVID-19 vaccine a huge challenge globally: WHO experts
expresspharma
January 06, 2021
As India launches the world’s most ambitious and biggest vaccination drive against COVID-19, the country will encounter the formidable challenge of rapidly scaling up distribution of the vaccines to secure immunity for its entire populatio ...
-
Fighting counterfeiting requires a long-term battle and we need to start somewhere
expresspharma
January 06, 2021
COVID-19 vaccines are here but there are reports about a surge in the cyber attacks in the pharma sector as well. How can a data breach become a critical, serious event?
-
Concerns raised over India’s approval of COVID-19 vaccine with incomplete data
europeanpharmaceuticalreview
January 05, 2021
The All India Drug Action Network has said it is “shocked” India has given approval to Covaxin, a COVID-19 vaccine with a lack of peer reviewed safety and efficacy data.
-
Moderna’s COVID-19 vaccine is 94 percent effective, according to trial results
europeanpharmaceuticalreview
January 05, 2021
Phase III trial data suggests the mRNA-1273 vaccine is safe and highly effective at preventing COVID-19 in adults.
-
Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin
expresspharma
January 05, 2021
A team from ABCVAC will travel to India for further discussions with Bharat Biotech, as per reports.